Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

JNJ

Johnson & Johnson

Jul 26 • 04:00PM ET

160.64

Dollar change +1.00
Percentage change 0.63	%

Healthcare • Drug Manufacturers - General • USA • NYSE

Stock Detail • Compare Perf. • Financials • Options Chain • Save to Portfolio • Create Alert

Held by: VTI VOO SPY IVV VTV XLV VIG VYM QUAL IWD

Scroll to Statements

Index	DJIA, S&P 500	P/E	23.22	EPS (ttm)	6.92	Insider Own	0.16%	Shs Outstand	2.41B	Perf Week	3.85%
Market Cap	386.61B	Forward P/E	15.02	EPS next Y	10.69	Insider Trans	-1.74%	Shs Float	2.40B	Perf Month	9.41%
Income	17.03B	PEG	4.20	EPS next Q	2.21	Inst Own	72.63%	Short Float	0.75%	Perf Quarter	9.41%
Sales	86.57B	P/S	4.47	EPS this Y	0.86%	Inst Trans	-0.39%	Short Ratio	2.47	Perf Half Y	0.68%
Book/sh	29.72	P/B	5.40	EPS next Y	6.88%	ROA	8.79%	Short Interest	17.99M	Perf Year	-6.99%
Cash/sh	10.59	P/C	15.18	EPS next 5Y	5.53%	ROE	22.34%	52W Range	143.13 - 175.97	Perf YTD	2.49%
Dividend Est.	4.65 (2.90%)	P/FCF	19.04	EPS past 5Y	-0.27%	ROI	16.51%	52W High	-8.71%	Beta	0.50
Dividend TTM	4.81 (2.99%)	Quick Ratio	0.85	Sales past 5Y	1.31%	Gross Margin	68.75%	52W Low	12.23%	ATR (14)	2.54
Dividend Ex-Date	Aug 27, 2024	Current Ratio	1.07	EPS Y/Y TTM	44.66%	Oper. Margin	26.05%	RSI (14)	72.78	Volatility	1.84% 1.62%
Employees	131900	Debt/Eq	0.58	Sales Y/Y TTM	-11.50%	Profit Margin	19.68%	Recom	2.17	Target Price	171.12
Option/Short	Yes / Yes	LT Debt/Eq	0.44	EPS Q/Q	-1.24%	Payout	84.93%	Rel Volume	1.15	Prev Close	159.64
Sales Surprise	0.52%	EPS Surprise	4.01%	Sales Q/Q	-12.12%	Earnings	Jul 17 BMO	Avg Volume	7.28M	Price	160.64
SMA20	6.82%	SMA50	7.80%	SMA200	4.74%	Trades		Volume	8,337,265	Change	0.63%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-23-24	Downgrade	Daiwa Securities	Outperform → Neutral	$160 → $150
May-30-24	Resumed	Goldman	Neutral	$160
Apr-18-24	Upgrade	HSBC Securities	Hold → Buy	$170
Dec-13-23	Downgrade	Wells Fargo	Overweight → Equal Weight	$170 → $163
Dec-01-23	Upgrade	UBS	Neutral → Buy	$167 → $180
Oct-05-23	Initiated	RBC Capital Mkts	Outperform	$178
Sep-06-23	Initiated	HSBC Securities	Hold	$175
May-30-23	Resumed	Citigroup	Buy	$185
Mar-29-23	Initiated	UBS	Neutral	$164
Mar-01-23	Initiated	Guggenheim	Neutral	$161
Nov-18-22	Initiated	Credit Suisse	Neutral	$170
Oct-18-22	Initiated	Barclays	Equal Weight	$175
Oct-14-22	Reiterated	BofA Securities	Neutral	$185 → $178
Jun-22-22	Initiated	Daiwa Securities	Outperform
May-23-22	Resumed	SVB Leerink	Outperform	$200
Apr-06-22	Resumed	Morgan Stanley	Equal-Weight	$173
Mar-16-22	Downgrade	Bernstein	Outperform → Mkt Perform	$180 → $183
Mar-02-22	Resumed	BofA Securities	Neutral	$185
Dec-17-21	Initiated	Goldman	Neutral	$161
Dec-15-21	Reiterated	Citigroup	Buy	$192 → $195

Show Previous Ratings

Today 09:38AM	Courts, Congress Likely to Stand in Way of J&J's Third Texas Two-Step Plan (Business Wire)
Jul-25-24 04:16PM	'Never going to be the same': How Nvidia is trying to revolutionize healthcare (Yahoo Finance)
12:53PM	AC Immune wins FDA fast track for Alzheimers vaccine (Pharmaceutical Technology)
11:33AM	Sandoz launches ustekinumab biosimilar in Europe (Pharmaceutical Technology)
08:53AM	AstraZeneca Posts Earnings Beat, Lifts Guidance on Strong Sales (Investopedia)
07:00AM	Loading…
07:00AM	How To Earn $100 Per Month From Johnson & Johnson Stock (Benzinga)
Jul-24-24 05:49PM	Claimants Face 5pm ET Fri Deadline to Accept $8 Billion Settlement in J&J Suit, Ovarian Cancer Survivors Urge Others to Vote Yes (Exec Edge)
09:00AM	Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know (Zacks)
03:52AM	J&J forecast to dominate BiTE market (Pharmaceutical Technology)
Jul-23-24 04:00PM	Johnson & Johnson to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference (Business Wire)
11:14AM	J&J drops Addexs epilepsy treatment after flunking in Phase II (Pharmaceutical Technology)
07:03AM	Covid-19 vaccines: serious adverse events explained (Pharmaceutical Technology)
07:00AM	5 Best Dividend Stocks For Roth IRA According To Reddit (Benzinga)
05:30AM	J&J Allies With Mass-Tort Specialists to Seal $8 Billion Talc Settlement (The Wall Street Journal)
04:12AM	Johnson & Johnson submits sNDA for SPRAVATO to treat depression (Pharmaceutical Technology)
05:00PM	Loading…
Jul-22-24 05:00PM	Achieve Financial Independence with This Dividend Stock in 10 Years (Benzinga)
02:40PM	Johnson & Johnson says its ketamine-based drug can treat depression (Quartz)
11:59AM	Lawyers for Ovarian Cancer Victims Urge NO Vote on J&J's Latest Bankruptcy Plan (Business Wire)
08:00AM	Beyond Market Price: Uncovering Johnson & Johnson's Intrinsic Value (GuruFocus.com)
08:00AM	Johnson & Johnson seeks U.S. FDA approval of SPRAVATO (esketamine) as the first and only monotherapy for adults with treatment-resistant depression (PR Newswire)
08:00AM	J&J seeks expanded approval for antidepressant Spravato (BioPharma Dive)
Jul-20-24 07:00AM	What a List of the Best-Performing Stocks of the Past Century Tells Us (Investopedia)
Jul-19-24 11:17AM	Stock Market Rotation Gets Rough; ASML, Eli Lilly, CrowdStrike, UnitedHealth In Focus: Weekly Review (Investor's Business Daily)
05:00AM	A new weight loss pill, Ozempic boosts protein sales, J&J's cancer drug: Pharma news roundup (Quartz)
Jul-18-24 07:13PM	Analyst Report: Johnson & Johnson (Morningstar Research)
09:00AM	3 High Yield Healthcare Giants With Consistent Dividend Growth: Johnson & Johnson, Merck, And Quest Diagnostics (Benzinga)
07:45AM	A Top-Tier Dividend Stock Every Passive-Income Investor Should Consider (Motley Fool)
05:40AM	Is Johnson & Johnson a Buy Now? (Motley Fool)
04:32AM	Johnson & Johnsons Q2 2024 net earnings drop 12.8% to $4.6bn (Pharmaceutical Technology)
04:25AM	2 Magnificent S&P 500 Dividend Stocks Down 19% and 41% to Buy and Hold Forever (Motley Fool)
02:30AM	Loading…
02:30AM	Q2 2024 Johnson & Johnson Earnings Call (Thomson Reuters StreetEvents)
Jul-17-24 06:32PM	China chip exports, Fed rate cut optimism: Market Domination (Yahoo Finance Video)
06:14PM	Why Johnson & Johnson Stock Was a Winner on Wednesday (Motley Fool)
04:28PM	These Stocks Moved the Most Today: Nvidia, AMD, ASML, TSMC, Intel, J&J, Five Below, GitLab, and More (Barrons.com)
04:13PM	Johnson & Johnson Makes A Bullish Move On A Second-Quarter Beat With Caveats (Investor's Business Daily)
03:39PM	22 Of 30 Dow Stocks Are Up. 3M Is One of Those. (Barrons.com)
03:00PM	Johnson & Johnson (JNJ) Q2 2024 Earnings Call Transcript (Motley Fool)
02:47PM	These Stocks Are Moving the Most Today: Nvidia, AMD, ASML, TSMC, Intel, J&J, Five Below, GitLab, and More (Barrons.com)
02:05PM	Johnson And Johnson Continues To Focus On Medical Innovation (Benzinga)
01:53PM	Small caps, biggest themes in the media landscape: Catalysts (Yahoo Finance Video)
01:47PM	Chip stocks under pressure, pharmaceuticals rise: Morning Brief (Yahoo Finance Video)
01:30PM	Johnson & Johnson CFO outlines Tremfya, Rybrevant launches (Yahoo Finance Video)
12:38PM	Johnson & Johnson CFO talks Q2 earnings, medtech business (Yahoo Finance Video)
11:27AM	J&J (JNJ) Q2 Earnings & Sales Top, EPS View Cut on M&A Costs (Zacks)
11:07AM	Johnson & Johnson Stock Rises After Earnings (Barrons.com)
10:16AM	Stocks to Watch Wednesday: J&J, Nvidia, TSM, AMD (The Wall Street Journal)
10:07AM	Johnson & Johnson's cancer drug Darzalex could replace Stelar as the company's best-selling drug (Quartz)
09:57AM	JNJ posts Q2 earnings beat, but slashes 2024 profit forecast (Yahoo Finance Video)
09:39AM	Johnson & Johnson Posts Mixed Earnings, Shifts Full-Year Guidance (Investopedia)
09:30AM	Johnson & Johnson (JNJ) Reports Q2 Earnings: What Key Metrics Have to Say (Zacks)
08:17AM	Johnson & Johnson Earnings Top, But Dow Stock Lowers Guidance (Investor's Business Daily)
08:14AM	Johnson & Johnson's Q2 Earnings: Revenue And Profit Beat On Strong Pharma Sales, Annual Profit Outlook Lowered On M&A Costs (Benzinga)
07:53AM	5 Things to Know Before the Stock Market Opens (Investopedia)
07:47AM	Johnson & Johnson Q2 Adj. EPS Beats View, Cuts FY24 Earnings Forecast (RTT News)
07:30AM	Johnson & Johnson (JNJ) Beats Q2 Earnings and Revenue Estimates (Zacks)
06:41AM	Johnson & Johnson Stock Slips After Earnings (Barrons.com)
06:29AM	Johnson & Johnson: Q2 Earnings Snapshot (Associated Press Finance)
06:25AM	Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2024 (Business Wire)
06:22AM	J&J beats Wall Street estimates on strong drug sales (Reuters)
06:20AM	Johnson & Johnson reports Q2 2024 results (Business Wire)
Jul-16-24 04:34PM	United Airlines, JNJ earnings, housing data: What to Watch (Yahoo Finance Video)
04:24PM	Johnson & Johnson (JNJ): Did this Dividend Stock Outperform During the Last Quarter? (Insider Monkey)
04:00PM	Johnson & Johnson Earnings Are Coming. It Took Steps to Put Its Talc Issues Behind It. (Barrons.com)
08:48AM	15 Best Stocks For Dividends (Insider Monkey)
06:32AM	J&J, Abbott and Intuitive start medtech earnings season (MedTech Dive)
06:15AM	If You Can Only Buy One Dow Stock in July, It Better Be One of These 3 Names (InvestorPlace)
Jul-15-24 10:47AM	J&J (JNJ) Stock Before Q2 Earnings: To Buy or Not to Buy? (Zacks)
08:05AM	NKGen Biotech Appoints Dr. Marco Gottardis to its Board of Directors (GlobeNewswire)
06:38AM	Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever (Motley Fool)
Jul-14-24 12:16PM	30 Wealthiest People in Switzerland (Insider Monkey)
12:10PM	25 Best Companies to Work For in the World (Insider Monkey)
09:31AM	2 Healthcare Stocks to Buy Hand Over Fist This Month (Motley Fool)
09:00AM	Netflix results, retail sales, and a chip update: What to watch this week (Yahoo Finance)
07:00AM	What To Expect in the Markets This Week (Investopedia)
04:27AM	3 High-Yield Dividend Stocks That Still Look Like Bargains (Motley Fool)
Jul-12-24 05:16PM	Lots of earnings, price of stamps increasing: What to watch (Yahoo Finance Video)
09:15AM	Unlocking Q2 Potential of Johnson & Johnson (JNJ): Exploring Wall Street Estimates for Key Metrics (Zacks)
06:23AM	3 Essential Stocks for Building a Recession-Proof Portfolio (InvestorPlace)
Jul-11-24 02:53PM	J&J asserts its place in atopic dermatitis space with Yellow Jersey acquisition (Pharmaceutical Technology)
07:30AM	Johnson & Johnson Strengthens Pipeline to Lead in Atopic Dermatitis With the Completion of the Acquisition of Yellow Jersey Therapeutics, Gaining Ownership of NM26 (Business Wire)
04:51AM	3 Magnificent Dow Stocks That Are No-Brainer Buys for the Second Half of 2024 (Motley Fool)
Jul-10-24 05:45PM	Johnson & Johnson (JNJ) Outpaces Stock Market Gains: What You Should Know (Zacks)
10:13AM	Energised US market opportunity for pulsed field ablation (Medical Device Network)
07:00AM	3 Undervalued Stocks Set to Outperform the Market in 2024 (InvestorPlace)
Jul-09-24 10:01AM	Johnson & Johnson (JNJ): One of the Best Blue Chip Dividend Stocks Right Now According to Hedge Funds? (Insider Monkey)
09:25AM	10 Best Blue Chip Dividend Stocks To Buy (Insider Monkey)
Jul-08-24 02:01PM	Long-Term Dividend Growth And Recent Hikes: Johnson & Johnson, Oshkosh, And ManpowerGroup (Benzinga)
08:00AM	Johnson & Johnson: An Exploration into Its Intrinsic Value (GuruFocus.com)
06:45AM	7 Diversified Income Powerhouses for Lifelong Cash Flow (InvestorPlace)
Jul-05-24 01:43PM	3 Rock-Solid Income Machines to Hold for Decades (InvestorPlace)
11:32AM	3 Dividend Aristocrats Now Cheaper Than During the 2008 Financial Crisis (InvestorPlace)
10:10AM	J&J (JNJ) Trades Below 200 & 50-Day Moving Averages: Buy the Dip? (Zacks)
Jul-04-24 02:13PM	FDA Favorites: 3 Biotech Stocks on the Verge of Major Approvals (InvestorPlace)
12:00PM	Upcoming Stock Spinoffs: Should You Pounce or Pass? (InvestorPlace)
06:00AM	3 High-Yield Dividend Stocks/ETFs to Buy Hand Over Fist in July (Motley Fool)
Jul-03-24 03:32PM	7 Blue-Chip Cash Cows to Milk for Steady Income (InvestorPlace)
10:00AM	7 Safe Haven Stocks to Buy Before the Next Market Correction (InvestorPlace)
08:00AM	How Small Biotech Halozyme, With A 41% Run, Is Getting Under Your Skin (Investor's Business Daily)
08:00AM	Health Canada Authorizes RYBREVANT® (amivantamab) in Combination with Carboplatin and Pemetrexed as the Only Targeted First-line Treatment Approved for Patients with Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations (PR Newswire)
07:37AM	Beacon raises $170M for eye gene therapy; J&J confirms Carvykti survival benefit (BioPharma Dive)

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Broadhurst Vanessa	EVP, Global Corp Affairs	Jul 08 '24	Option Exercise	0.00	9,809	0	24,852	Jul 09 05:48 PM
REED JOHN C	EVP, Innovative Medicine, R&D	May 01 '24	Option Exercise	0.00	22,255	0	22,561	May 03 04:31 PM
Broadhurst Vanessa	EVP, Global Corp Affairs	Mar 13 '24	Sale	162.16	8,891	1,441,765	15,043	Mar 13 04:36 PM
JOHNSON & JOHNSON	10% Owner	Feb 29 '24	Option Exercise	0.72	3,855	2,792	4,103,430	Mar 06 03:42 PM
JOHNSON & JOHNSON	10% Owner	Feb 16 '24	Sale	25.81	3,725	96,142	4,099,575	Mar 06 03:42 PM
Decker Robert J	VP Corporate Controller	Feb 13 '24	Option Exercise	0.00	313	0	19,059	Feb 15 04:53 PM
Broadhurst Vanessa	EVP, Global Corp Affairs	Feb 13 '24	Option Exercise	0.00	408	0	24,143	Feb 15 04:53 PM
Forminard Elizabeth	Executive VP, General Counsel	Feb 13 '24	Option Exercise	0.00	651	0	8,576	Feb 15 04:53 PM
Duato Joaquin	CEO and Chairman of the Board	Feb 13 '24	Option Exercise	0.00	3,470	0	364,809	Feb 15 04:53 PM
Hait William	See Remarks	Feb 13 '24	Option Exercise	0.00	834	0	39,074	Feb 15 04:53 PM
Fasolo Peter	Exec VP, Chief HR Officer	Feb 13 '24	Option Exercise	0.00	925	0	112,550	Feb 15 04:53 PM
Schmid Timothy	EVP, WW Chair, MedTech	Feb 13 '24	Option Exercise	0.00	499	0	13,290	Feb 15 04:53 PM
Swanson James D.	EVP, CIO	Feb 13 '24	Option Exercise	0.00	447	0	14,765	Feb 15 04:53 PM
Taubert Jennifer L	EVP, WWC. Innovative Medicine	Feb 13 '24	Option Exercise	0.00	1,302	0	155,517	Feb 15 04:53 PM
Wolk Joseph J	Exec VP, CFO	Feb 13 '24	Option Exercise	0.00	1,780	0	69,663	Feb 15 04:53 PM
Wengel Kathryn E	EVP, Chief TO and Risk Officer	Feb 13 '24	Option Exercise	0.00	651	0	82,599	Feb 15 04:53 PM
Decker Robert J	VP Corporate Controller	Feb 12 '24	Option Exercise	0.00	1,912	0	19,269	Feb 14 06:36 PM
Duato Joaquin	CEO and Chairman of the Board	Feb 12 '24	Option Exercise	0.00	36,618	0	377,239	Feb 14 06:36 PM
Taubert Jennifer L	EVP, WWC. Innovative Medicine	Feb 12 '24	Option Exercise	0.00	26,202	0	167,618	Feb 14 06:36 PM
Forminard Elizabeth	Executive VP, General Counsel	Feb 12 '24	Option Exercise	0.00	2,859	0	8,959	Feb 14 06:36 PM
Wolk Joseph J	Exec VP, CFO	Feb 12 '24	Option Exercise	0.00	25,835	0	78,699	Feb 14 06:36 PM
Hait William	See Remarks	Feb 12 '24	Option Exercise	0.00	8,932	0	42,316	Feb 14 06:36 PM
Broadhurst Vanessa	EVP, Global Corp Affairs	Feb 12 '24	Option Exercise	0.00	4,701	0	25,081	Feb 14 06:36 PM
Wengel Kathryn E	EVP, Chief TO and Risk Officer	Feb 12 '24	Option Exercise	0.00	13,813	0	89,014	Feb 14 06:36 PM
Schmid Timothy	EVP, WW Chair, MedTech	Feb 12 '24	Option Exercise	0.00	5,736	0	15,678	Feb 14 06:36 PM
Swanson James D.	EVP, CIO	Feb 12 '24	Option Exercise	0.00	5,456	0	16,013	Feb 14 06:36 PM
Fasolo Peter	Exec VP, Chief HR Officer	Feb 12 '24	Option Exercise	0.00	14,960	0	118,644	Feb 14 06:36 PM
Duato Joaquin	CEO and Chairman of the Board	Feb 09 '24	Option Exercise	90.44	130,969	11,844,836	439,283	Feb 13 05:18 PM
Taubert Jennifer L	EVP, WW Chair, Pharmaceuticals	Feb 09 '24	Option Exercise	90.44	59,397	5,371,865	200,813	Feb 12 07:25 PM
Taubert Jennifer L	EVP, WW Chair, Pharmaceuticals	Feb 09 '24	Sale	156.27	59,397	9,281,969	141,416	Feb 12 07:25 PM
Taubert Jennifer L	EVP, WW Chair, Pharmaceuticals	Feb 08 '24	Option Exercise	0.00	3,739	0	143,329	Feb 12 07:25 PM
Decker Robert J	VP Corporate Controller	Feb 08 '24	Option Exercise	0.00	655	0	17,572	Feb 12 07:24 PM
Broadhurst Vanessa	EVP, Global Corp Affairs	Feb 08 '24	Option Exercise	0.00	1,880	0	21,083	Feb 12 07:24 PM
Hait William	See Remarks	Feb 08 '24	Option Exercise	0.00	3,059	0	34,497	Feb 12 07:24 PM
Fasolo Peter	Exec VP, Chief HR Officer	Feb 08 '24	Option Exercise	0.00	2,135	0	104,465	Feb 12 07:24 PM
Schmid Timothy	EVP, WW Chair, MedTech	Feb 08 '24	Option Exercise	0.00	1,964	0	10,943	Feb 12 07:24 PM
Swanson James D.	See Remarks	Feb 08 '24	Option Exercise	0.00	1,868	0	11,111	Feb 12 07:24 PM
Forminard Elizabeth	Executive VP, General Counsel	Feb 08 '24	Option Exercise	0.00	979	0	6,463	Feb 12 07:24 PM
Wolk Joseph J	Exec VP, CFO	Feb 08 '24	Option Exercise	0.00	3,686	0	53,911	Feb 12 07:25 PM
Wengel Kathryn E	EVP, Chief TO and Risk Officer	Feb 08 '24	Option Exercise	0.00	1,971	0	67,905	Feb 12 07:25 PM
Duato Joaquin	CEO and Chairman of the Board	Feb 08 '24	Option Exercise	0.00	5,225	0	310,583	Feb 12 07:25 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

JNJ

Johnson & Johnson

Upgrade your FINVIZ experience